A Imai

No ORCID on file · 8 papers in corpus · active 1991-2014

Study types

  • article 6
  • letter 1
  • other 1

Condition tags

  • endometriosis 7
  • adenomyosis 3
  • dysmenorrhea 1
  • bladder_endometriosis 1
article 2014
Levonorgestrel-releasing intrauterine device used for dysmenorrhea: five-year literature review
Clinical and experimental obstetrics & gynecology ·doi:10.12891/ceog17042014

Intrauterine devices (IUDs) provide highly effective, long-term, safe, reversible contraception, and are the most widely used reversible contraceptive method worldwide. The levonorgestrel-releasing IUD (LNG-IUD), originally designed for lon…

article 2011
Novel [corrected] medical management of primary bladder endometriosis with dienogest: a case report.
Clinical and experimental obstetrics & gynecology

BACKGROUND: Because of its low incidence, medical treatment of has not yet been well established although surgical excision is generally considered effective. We report the first case of primary bladder endometriosis successfully managed wi…

article 2000
Gonadotropin-releasing hormone analog repairs reduced endometrial cell apoptosis in endometriosis in vitro
American Journal of Obstetrics and Gynecology ·doi:10.1067/mob.2000.104804
article 1998
A gonadotropin-releasing hormone analogue impairs glucose tolerance in a diabetic patient
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/s0301-2115(97)00158-9
article 1998
Drastic elevation of serum CA125, CA72-4 and CA19-9 levels during menses in a patient with probable endometriosis
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/s0301-2115(98)00003-7
letter 1994
Detection of inguinal endometriosis by magnetic resonance imaging (MRI)
International Journal of Gynecology & Obstetrics ·doi:10.1016/0020-7292(94)90581-9
other 1994
Presence of gonadotropin-releasing hormone receptor and its messenger ribonucleic acid in endometrial carcinoma and endometrium
Gynecologic oncology ·doi:10.1006/gyno.1994.1264

In support of a possible clinical use of gonadotropin-releasing hormone (Gn-RH) analogs in the treatment of the endometrial carcinoma, this study was undertaken to establish the presence and characteristics of Gn-RH receptor on endometrial …

article 1991
Rationale for frequency and dose of administration in gestrinone therapy for pelvic endometriosis in the experimental model of rabbit uterus
General pharmacology ·doi:10.1016/0306-3623(91)90014-w